Abound Wealth Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113K Sell
271
-498
-65% -$185K 0.02% 147
2026
Q1
$208K Buy
769
+454
+144% +$135K 0.05% 87
2025
Q4
$104K Buy
315
+71
+29% +$24.1K 0.02% 135
2025
Q3
$84.2K Buy
244
+29
+13% +$8.77K 0.02% 154
2025
Q2
$67K Sell
215
-50
-19% -$19.1K 0.02% 168
2025
Q1
$139K Sell
265
-1
-0.4% -$511 0.05% 89
2024
Q4
$135K Buy
266
+1
+0.4% +$568 0.04% 84
2024
Q3
$155K Hold
265
0.05% 73
2024
Q2
$135K Sell
265
-38
-13% -$18.6K 0.05% 73
2024
Q1
$150K Sell
303
-8
-3% -$4.07K 0.06% 69
2023
Q4
$164K Buy
311
+16
+5% +$8.53K 0.07% 68
2023
Q3
$149K Buy
295
+35
+13% +$17.2K 0.06% 63
2023
Q2
$125K Buy
260
+55
+27% +$26.9K 0.05% 67
2023
Q1
$97.1K Buy
205
+4
+2% +$1.93K 0.04% 75
2022
Q4
$107K Sell
201
-47
-19% -$24.9K 0.05% 63
2022
Q3
$125K Buy
+248
New +$130K 0.07% 54

Other funds holding UNH

Abound Wealth Management's UNH Position: Q2 2026 in Review

Abound Wealth Management reduced its UnitedHealth (UNH) stake by 65% in Q2 2026, selling an estimated $185K and leaving 271 shares worth $113K. The position accounts for 0.02% of the portfolio, ranked #147.

Abound Wealth Management first reported a position in UNH in Q3 2022 and has held it in 16 quarters since. The position peaked at $208K in Q1 2026. 1,733 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Abound Wealth Management held 271 shares of UnitedHealth worth $113K as of Q2 2026.
  • Abound Wealth Management sold 498 UnitedHealth shares in Q2 2026, an estimated $185K.
  • UnitedHealth made up 0.02% of Abound Wealth Management's portfolio in Q2 2026, its #147 holding.
  • Abound Wealth Management first reported a position in UnitedHealth in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's UnitedHealth position peaked at $208K in Q1 2026.
  • 1,733 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.